Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
about
Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study.Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul StudyB-Type Natriuretic Peptide (BNP) and Left Ventricular (LV) Function in Patients with ST-Segment Elevation Myocardial Infarction (STEMI).Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic feverValue of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese populationRelation between left ventricular contractile reserve during low dose dobutamine echocardiography and plasma concentrations of natriuretic peptidesBrain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceEvaluation of N-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein relationship with features of metabolic syndrome in high-risk subgroups for cardiovascular disease.Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.Brain natriuretic peptide predicts mortality in the elderly.Relation between N-terminal pro-brain natriuretic peptide values and invasively measured left ventricular hemodynamic indicesCorrelates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.A bioclinical pattern for the early diagnosis of cardioembolic stroke.Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample.Asymptomatic right ventricular dysfunction in surgically repaired adult tetralogy of fallot patients.Predictors of unfavourable prognosis in chronic Chagas' disease.Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload.Practical implications of current natriuretic peptide research.Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters.Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the Emergency Department with suspected acute coronary syndrome: possible role in selecting patients for follow up?
P2860
Q30479094-DD03BFCD-0885-4443-9793-397F5B834989Q30919400-DC9C00A1-0E8E-41C8-9677-A47B1BD9677BQ33830253-CBC5FBD3-CC50-4F02-AC72-9549236A4B93Q34625940-23F79DA5-8251-4558-8246-BC7EACD88029Q35154776-651E2984-B569-4E4F-84E8-A3BFF3AF1035Q35481345-B131A488-3227-4B9C-84FF-85C86B050EACQ35579682-6F90A454-7F9D-4378-8931-5BE92FB8F40EQ35582086-84BDF72F-E633-495B-A7F8-ABCD87D9ABA2Q35843114-F9D36DC7-5622-4F93-99F5-70B0E5BF9075Q36163932-6A11A0FD-9CB3-4176-8523-B7B8E5EF6089Q36236490-EEB897DD-3DE0-4D79-B3B8-EAFA11B72296Q36841331-FAB81826-1588-4D29-9CE7-0833F66FF54BQ37276402-A635B181-3A37-4580-9687-056D79CC5C47Q37449563-165A7BE5-3C24-4DC8-91B6-61B754441FA1Q37657775-21807283-72B6-455A-9D30-F7CD54B28F08Q38113247-0BDF77F5-43DF-4532-9E38-7E2B26A58E9FQ39490174-5758ED91-59C5-4EBF-B885-59469869D1BEQ40036645-9269EB0D-73AE-4F06-B355-6813F2EB26D4Q43871653-A28BB2BF-7784-4840-A1B4-D5FEAE77C2F1Q44366685-3FF9ADC1-EB45-4D08-98AC-599D6E8BBD4AQ48378465-06CEE7E5-1E90-4E2A-B0F7-CC7ED12C3BD0Q48468296-9E7D5CB4-0C91-4BCE-8EA5-0866017C8F3FQ48504660-F2EB10FC-5872-4177-AB52-A3F06F8D835FQ48624965-770C99E2-3567-4880-A680-667D2CF63084Q48784334-269D785D-88F1-47F0-AB18-752E03C6DE9BQ49281759-AEA21A74-EB4A-461C-9D8F-EA13FD46F36E
P2860
Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Plasma cardiac natriuretic pep ...... d left ventricular impairment.
@en
type
label
Plasma cardiac natriuretic pep ...... d left ventricular impairment.
@en
prefLabel
Plasma cardiac natriuretic pep ...... d left ventricular impairment.
@en
P2093
P2860
P356
P1433
P1476
Plasma cardiac natriuretic pep ...... d left ventricular impairment.
@en
P2093
P2860
P304
P356
10.1136/HRT.76.3.232
P407
P577
1996-09-01T00:00:00Z